Also in agreement with the results from ALS patient serum and CSF, both strands of miR-132 showed a similar decrease in LCLs of genetic ALS patients except for those carrying a mutation in the gene coding for SOD1 (Figure 4B). This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.